New-onset Blepharitis and Anti-TNF-Alpha Therapy in Patients with Crohn's Disease: A Case Series and Literature Review

Isr Med Assoc J. 2023 Dec;25(12):836-840.
No abstract available

Publication types

  • Review

MeSH terms

  • Adalimumab / adverse effects
  • Crohn Disease* / drug therapy
  • Humans
  • Infliximab / adverse effects
  • Tumor Necrosis Factor Inhibitors / adverse effects
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor Inhibitors
  • Infliximab
  • Adalimumab
  • Tumor Necrosis Factor-alpha